Global Trust Asset Management »

Impact Biomedical shares owned by Global Trust Asset Management

Quarter-by-quarter ownership of Impact Biomedical (IBO) shares owned by Global Trust Asset Management from 13F filings

Historical chart of Global Trust Asset Management investment in Impact Biomedical

Tip: Access up to 7 years of quarterly data

All positions including Impact Biomedical held by Global Trust Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Impact Biomedical by Global Trust Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.1k 1.8k 0.60

More positions owned by Global Trust Asset Management

Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr 3 7 Yr Treas Bd (IEI)
Lumentum Hldgs (LITE)
Apple (AAPL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Palantir Technologies Cl A (PLTR)
Nextera Energy (NEE)
Caterpillar (CAT)
Microsoft Corporation (MSFT)
Applied Optoelectronics (AAOI)
Applied Materials (AMAT)
Amazon (AMZN)

View all positions for Global Trust Asset Management

Top funds holding Impact Biomedical

Geode Capital Management
Vanguard Group
Vanguard Capital Management
Vanguard Fiduciary Trust
BlackRock
Two Sigma Investments
UBS Group
Vanguard Global Advisers
Susquehanna International
State Street Corporation
Northern Trust
Mason & Associates
Morgan Stanley
Global Trust Asset Management
Tower Research Capital

View all funds holding Impact Biomedical